Hodgkin's lymphoma Posts Page 2 on Medivizor
Navigation Menu

Hodgkin’s lymphoma Posts on Medivizor

Bone marrow biopsy versus PET/CT scan for staging classical Hodgkin lymphoma

Posted by on May 29, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined whether bone marrow biopsies are necessary if PET scans are used to stage classical Hodgkin lymphoma. The study concluded that patients can safely be staged with PET/CT scans without bone marrow biopsy. Some background Hodgkin lymphoma (HL) is widely considered a curable disease. Between 4 and 11% of patients with...

Read More

Long term follow-up study of reduced intensity treatments for early stage Hodgkin lymphoma

Posted by on May 29, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study provided a long-term follow-up of patients diagnosed with early-stage Hodgkin lymphoma. The study concluded that current strategies for reduced intensity treatment of early-stage Hodgkin lymphoma are generally safe and effective.  Some background Hodgkin lymphoma (HL) is generally considered a curable disease....

Read More

Adding rituximab to escalated BEACOPP therapy in Hodgkin Lymphoma patients with a positive PET scan

Posted by on May 15, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study assessed the effectiveness of using escalated BEACOPP plus rituximab chemotherapy in patients with advanced stage Hodgkin Lymphoma. The study concluded that adding rituximab to the standard escalated BEACOPP regimen did not significantly improve time to disease progression. Some background Hodgkin Lymphoma (HL) is...

Read More

The use of donor stem cell transplantation in patients with relapsed Hodgkin lymphoma

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors examined haploidentical (matched donor) stem cell transplantation (haplo-SCT) as a treatment for patients who relapsed after autologous stem cell transplantation. The study concluded that haplo-SCT is a valid treatment for patients with relapsed Hodgkin lymphoma. Some background Most cases of Hodgkin lymphoma (HL) can be...

Read More

Late effects of Hodgkin lymphoma in teenager and young adult survivors

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the amount of late complications that affect teenage and young adult Hodgkin lymphoma survivors. The authors concluded that these patients had higher risks of developing other cancers and getting sick compared to the general population. Some background Hodgkin lymphoma (HL) is the most common cancer among...

Read More

Use of brentuximab vedotin in Hodgin lymphoma patients before allogenic stem cell transplantation

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined the outcomes for patients who received brentuximab vedotin before allogenic stem cell transplantation. The authors concluded that patients treated with brentuximab vedotin had generally good outcomes. Some background Hodgkin lymphoma (HL) is generally considered a curable disease. However, some patients will not...

Read More

Risk factors for relapse after autologous stem cell transplantation

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors looked at several risk factors that may be associated with relapse after autologous stem cell transplantation (ASCT). The authors found that 5 risk factors were independently associated with relapse after ASCT: stage IV cancer before ASCT; less than 3 months between previous treatment and relapse; performance status of 1 or...

Read More

Total lymphoid irradiation as part of a salvage regimen for patients with unresponsive Hodgkin Lymphoma

Posted by on Apr 9, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors looked at the long-term results of total lymphoid irradiation for patients with relapsed or unresponsive Hodgkin lymphoma. The authors concluded that total lymphoid irradiation combined with high-dose chemotherapy is a safe and effective treatment for patients with relapsed or unresponsive Hodgkin lymphoma. Some background...

Read More